tradingkey.logo
tradingkey.logo

Bionano Genomics Inc

BNGO
1.600USD
+0.010+0.63%
終値 12/19, 16:00ET15分遅れの株価
15.57M時価総額
損失額直近12ヶ月PER

Bionano Genomics Inc

1.600
+0.010+0.63%

詳細情報 Bionano Genomics Inc 企業名

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Incの企業情報

企業コードBNGO
会社名Bionano Genomics Inc
上場日Aug 01, 2018
最高経営責任者「CEO」Holmlin (R. Erik)
従業員数98
証券種類Ordinary Share
決算期末Aug 01
本社所在地9540 Towne Centre Drive
都市SAN DIEGO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号92121
電話番号18588887600
ウェブサイトhttps://bionano.com/
企業コードBNGO
上場日Aug 01, 2018
最高経営責任者「CEO」Holmlin (R. Erik)

Bionano Genomics Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
会社名
収益
比率
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%
地域別USD
会社名
収益
比率
EMEIA
3.23M
47.94%
Americas
2.93M
43.46%
Asia Pacific
579.00K
8.60%
事業別
地域別
事業別USD
会社名
収益
比率
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%

株主

更新時刻: Thu, Dec 4
更新時刻: Thu, Dec 4
株主統計
種類
株主統計
株主統計
比率
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
UBS Financial Services, Inc.
0.62%
他の
84.47%
株主統計
株主統計
比率
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
UBS Financial Services, Inc.
0.62%
他の
84.47%
種類
株主統計
比率
Investment Advisor
6.44%
Corporation
5.16%
Individual Investor
3.19%
Hedge Fund
2.07%
Investment Advisor/Hedge Fund
0.37%
Research Firm
0.10%
他の
82.67%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
2023Q3
336
90.39K
20.40%
+284.00
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Lincoln Alternative Strategies LLC
525.00K
5.42%
+525.00K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.91%
+475.00K
--
Sep 16, 2025
Abbe (Richard)
157.50K
1.63%
+157.50K
--
Sep 16, 2025
Iroquois Capital Management, LLC
367.50K
3.8%
+367.50K
--
Sep 16, 2025
UBS Financial Services, Inc.
2.31K
0.02%
+397.00
+20.79%
Jun 30, 2025
Geode Capital Management, L.L.C.
18.87K
0.19%
+3.37K
+21.70%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
日付
種類
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1

よくある質問

Bionano Genomics Incの上位5名の株主は誰ですか?

Bionano Genomics Incの上位5名の株主は以下のとおりです。
Lincoln Alternative Strategies LLCは525.00K株を保有しており、これは全体の5.42%に相当します。
Heights Capital Management, Inc.は475.00K株を保有しており、これは全体の4.91%に相当します。
Abbe (Richard)は157.50K株を保有しており、これは全体の1.63%に相当します。
Iroquois Capital Management, LLCは367.50K株を保有しており、これは全体の3.80%に相当します。
UBS Financial Services, Inc.は2.31K株を保有しており、これは全体の0.02%に相当します。

Bionano Genomics Incの株主タイプ上位3種は何ですか?

Bionano Genomics Incの株主タイプ上位3種は、
Lincoln Alternative Strategies LLC
Heights Capital Management, Inc.
Abbe (Richard)

Bionano Genomics Inc(BNGO)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Bionano Genomics Incの株式を保有している機関は123社あり、保有株式の総市場価値は約914.11Kで、全体の2.31%を占めています。2025Q3と比較して、機関の持ち株は-0.26%増加しています。

Bionano Genomics Incの最大の収益源は何ですか?

FY2025Q2において、Consumables部門がBionano Genomics Incにとって最大の収益を生み出しており、その金額は3.28Mで、全収益の48.66%を占めています。
KeyAI